Inhibitory effect of bis(2-aminohexyl) disulfide and bis(2-amino-3-phenylpropyl) disulfide on several mouse inflammations.

The anti-inflammatory profile of the analogues of bis(2-aminopropyl) disulfide dihydrochloride with butyl (compd. II) and phenyl (compd. III) instead of the methyl group was studied in several mouse models related to phagocyte functions. The test samples were administered 2-3 h before the inflammatory stimulation or the peak of inflammation. Subcutaneously administered, compds. II and III significantly inhibited serotonin-induced paw edema in a dose-dependent manner (50% inhibitory dose values: 10 and 5 mg/kg, respectively), when orally administered at 25 mg/kg, these compounds were significantly effective, but their potencies were weaker. Neither compound had any irritant activity when administered at a dose of 12.5 micrograms/5 microliters/paw into the paw. In a sheep red blood cells (SRBC)-induced delayed-type hypersensitivity (DTH) reaction model, compd. II (25 mg/kg, s.c.) significantly inhibited the DTH responses when administered at two different times in relation to the time of challenge. However, there was only slight inhibition by compd. III (25 mg/kg, s.c.) on paw edema formation when administered 14 h after secondary immune response. In a model of experimental acute hepatic failure induced by successive injections of Propionibacterium acnes and lipopolysaccharide, both compounds increased mouse survived, compared with the control mice, and kept the serum levels of components involved in hepatic failure to nearly normal levels. These results demonstrate that compds. II and III possess an inhibitory effect on inflammation related to phagocytes.     

Remarkably high catalytic activity of the Ru(III)(edta)/H2O2 system towards degradation of the azo-dye Orange II

The Ru(III)(edta)/H(2)O(2) system (edta(4-) = ethylenediaminetretaacetate) was found to degrade the azo-dye Orange II at remarkably high efficiency under ambient conditions. Catalytic degradation of the dye was studied by using rapid-scan spectrophotometry as a function of [H(2)O(2)], [Orange II] and pH. Spectral analyses and kinetic data point towards a catalytic pathway involving the rapid formation of [Ru(III)(edta)(OOH)](2-) followed by the immediate subsequent degradation of Orange II prior to the conversion of [Ru(III)(edta)(OOH)](2-) to [Ru(IV)(edta)(OH)](-) and [Ru(V)(edta)(O)](-)via homolysis and heterolysis of the O-O bond, respectively. The higher oxidation state Ru(IV) and Ru(V) complexes react three orders of magnitude slower with Orange II than the Ru(III)-hydroperoxo complex. In comparison to biological oxygen transfer reactions, the Ru(edta) complexes show the reactivity order Compound 0 ? Compounds I and II.     

Reductions by titanium(II) as catalyzed by titanium(IV)

The cobalt(III) complexes, [(NH3)5CoBr]2+ and [(NH3)5CoI]2+ are reduced by Ti(II) solutions containing Ti(IV), generating nearly linear (zero-order) profiles that become curved only during the last few percent of reaction. Other Co(III)-Ti(II) systems exhibit the usual exponential traces with rates proportional to [Co(III)]. Observed kinetics of the biphasic catalyzed Ti(II)-Co(III)Br and Ti(II)-Co(III)I reactions support the reaction sequence: [Ti(II)(H20)n]2+ + [Ti(IV)F5]- (k1)<==>(k -1) [Ti(II)(H2O)(n-1)]2+ + [(H2O)Ti(IV)F5]-, [Ti(II)(H2O)(n-1)]2+ + Co(III) (k2)--> Ti(III) + Co(II) with rates determined mainly by the slow Ti(IV)-Ti(II) ligand exchange (k1 = 9 x 10(-3) M(-1) s(-1) at 22 degrees C). Computer simulations of the catalyzed Ti(II)-Co(III) reaction in perchlorate-triflate media yield relative rates for reduction by the proposed active [Ti(II)(H2O)(n-1)]2+ intermediate; k(Br)/k(I) = 8.     

Probing metal binding in the 8-17 DNAzyme by TbIII luminescence spectroscopy

Metal-dependent cleavage activities of the 8-17 DNAzyme were found to be inhibited by Tb(III) ions, and the apparent inhibition constant in the presence of 100 microM of Zn(II) was measured to be 3.3+/-0.3 microM. The apparent inhibition constants increased linearly with increasing Zn(II) concentration, and the inhibition effect could be fully rescued with addition of active metal ions, indicating that Tb(III) is a competitive inhibitor and that the effect is completely reversible. The sensitized Tb(III) luminescence at 543 nm was dramatically enhanced when Tb(III) was added to the DNAzyme-substrate complex. With an inactive DNAzyme in which the GT wobble pair was replaced with a GC Watson-Crick base pair, the luminescence enhancement was slightly decreased. In addition, when the DNAzyme strand was replaced with a complete complementary strand to the substrate, no significant luminescence enhancement was observed. These observations suggest that Tb(III) may bind to an unpaired region of the DNAzyme, with the GT wobble pair playing a role. Luminescence lifetime measurements in D(2)O and H(2)O suggested that Tb(III) bound to DNAzyme is coordinated by 6.7+/-0.2 water molecules and two or three functional groups from the DNAzyme. Divalent metal ions competed for the Tb(III) binding site(s) in the order Co(II)>Zn(II)>Mn(II)>Pb(II)>Ca(II) approximately Mg(II). This order closely follows the order of DNAzyme activity, with the exception of Pb(II). These results indicate that Pb(II), the most active metal ion, competes for Tb(III) binding differently from other metal ions such as Zn(II), suggesting that Pb(II) may bind to a different site from that for the other metal ions including Zn(II) and Tb(III).     

Thermochemical Properties of Neutral Complexes in Layer Silicates I. [Ni(4-Etpy)4(NCS)2] complex in montmorillonite and pillared montmorillonites

The stoichiometry of thermal decomposition and enthalpy and structural changes were studied for the compounds formed by penetration of [Ni(4-Etpy)4(NCS)2] (I) into Ca-montmorillonite (II) or Cr-, Zr- and Al-pillared analogues (III, IV and V, respectively). The mass fractions of complex I in II, III, IV or V are different. It was found for all studied compounds that the release of L (L=4-Etpy) is a three-step process (-2L, -1L, -1L), and differences occurred in enthalpy changes (δH in kJ per mole of I) corresponding to the individual processes. These differences and the changes in diffraction and spectral properties of the species formed after intercalation are assumed to have their roots in different intramolecular guest-host interactions in the studied compounds. This revised version was published online in July 2006 with corrections to the Cover Date.     

Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds

Various analogues of a new antidiabetic agent, pioglitazone (AD-4833, U-72107), were synthesized in order to study in more detail the structure-activity relationships of this class of drug. 5-(4-Pyridylalkylthiobenzyl)-2,4-thiazolidinediones (I), thia-analogues of pioglitazone, were prepared via Meerwein arylation of the alkylthioanilines (IV). 5-(4-Pyridylalkoxybenzylidene)-2,4-thiazolidinediones (IIa) and related heterocyclic analogues (IIb) were synthesized by Knoevenagel condensation of the aldehydes (VIII) with the corresponding azolidinones. Compounds I and II were evaluated for hypoglycemic and hypolipidemic activity in genetically obese and diabetic yellow KK (KKAy) mice. Several 5-[4-[2-(2-pyridyl)ethoxy]-benzylidene]-2,4- thiazolidinediones (IIa) were equipotent to pioglitazone. However, the thia-analogues (I) and the benzylideneheterocycles (IIb) had decreased activity. Catalytic hydrogenation of the 5-benzylidene analogue (14) was found to be a convenient new synthetic method for pioglitazone. The configuration of 14 is also discussed.     

Electron transfer. 157. Reactions of hypervalent manganese species with S(2) metal-ion reductants

Solutions of the complexes of hypervalent manganese, [Mn(III)(C(2)O(4))(3)](3)(-) (in oxalate buffers), [Mn(IV)(bigH)(3)](4+) (in biguanide buffers), and [(bipy)(2)Mn(III)(O)(2)Mn(IV)(bipy)(2)](3+) (in bipyridyl buffers) may be reduced by s(2) center reductants In(I), Sn(II), and Ge(II), yielding Mn(II) quantitatively. In all cases, rates are determined by the initial act of electron transfer, giving an s(1) transient (In(II), Sn(III), or Ge(III)); subsequent steps are rapid and kinetically silent. The In(I)-Mn(III) and Ge(II)-Mn(III) reactions are inhibited by added oxalate, whereas the Sn(II)-(Mn(III)Mn(IV)) reaction is strongly accelerated by Cl(-). The In(I)-Mn(IV) reaction is complicated by formation of a 1:1 addition compound In(I).Mn(IV). We find no evidence for two-unit steps in any of these systems.     

Sequential electron-transfer and proton-transfer pathways in hydride-transfer reactions from dihydronicotinamide adenine dinucleotide analogues to non-heme oxoiron(IV) complexes and p-chloranil. Detection of radical cations of NADH analogues in acid-promoted hydride-transfer reactions

Hydride transfer from dihydronicotinamide adenine dinucleotide (NADH) analogues, such as 10-methyl-9,10-dihydroacridine (AcrH 2) and its derivatives, 1-benzyl-1,4-dihydronicotinamide (BNAH), and their deuterated compounds, to non-heme oxoiron(IV) complexes such as [(L)Fe (IV)(O)] (2+) (L = N4Py, Bn-TPEN, and TMC) occurs to yield the corresponding NAD (+) analogues and non-heme iron(II) complexes in acetonitrile. Hydride transfer from the NADH analogues to p-chloranil (Cl 4Q) also occurs to produce the corresponding NAD (+) analogues and the hydroquinone anion (Cl 4QH (-)). The logarithms of the observed second-order rate constants (log k H) of hydride transfer from NADH analogues to non-heme oxoiron(IV) complexes are linearly correlated with those of hydride transfer from the same series of NADH analogues to Cl 4Q, including similar kinetic deuterium isotope effects. The log k H values of hydride transfer from NADH analogues to non-heme oxoiron(IV) complexes are also linearly correlated with those of deprotonation of the radical cations of NADH analogues. Such linear correlations indicate that overall hydride-transfer reactions of NADH analogues to both non-heme oxoiron(IV) complexes and Cl 4Q occur via electron transfer from NADH analogues to the oxoiron(IV) complexes, followed by rate-limiting deprotonation from the radical cations of NADH analogues and subsequent rapid electron transfer from the deprotonated radicals to the Fe(III) complexes to yield the corresponding NAD (+) analogues and the Fe(II) complexes. The electron-transfer pathway was accelerated by the presence of perchloric acid, and the resulting radical cations of NADH analogues were detected by electron spin resonance spectroscopy and UV-vis spectrophotometry in the acid-promoted hydride-transfer reactions from NADH analogues to non-heme oxoiron(IV) complexes. This result provides the first direct evidence that a hydride transfer from NADH analogues to non-heme oxoiron(IV) complexes proceeds via an electron-transfer pathway.     

Syntheses, crystal structures, and properties of six new lanthanide(III) transition metal tellurium(IV) oxyhalides with three types of structures

Solid-state reactions of lanthanide(III) oxide (and lanthanide(III) oxyhalide), transition metal halide (and transition metal oxide), and TeO(2) at high temperature lead to six new lanthanide transition metal tellurium(IV) oxyhalides with three different types of structures, namely, DyCuTe(2)O(6)Cl, ErCuTe(2)O(6)Cl, ErCuTe(2)O(6)Br, Sm(2)Mn(Te(5)O(13))Cl(2), Dy(2)Cu(Te(5)O(13))Br(2), and Nd(4)Cu(TeO(3))(5)Cl(3). Compounds DyCuTe(2)O(6)Cl, ErCuTe(2)O(6)Cl, and ErCuTe(2)O(6)Br are isostructural. The lanthanide(III) ion is eight-coordinated by eight oxygen atoms, and the copper(II) ion is five-coordinated by four oxygens and a halide anion in a distorted square pyramidal geometry. The interconnection of Ln(III) and Cu(II) ions by bridging tellurite anions results in a three-dimensional (3D) network with tunnels along the a-axis; the halide anion and the lone-pair electrons of the tellurium(IV) ions are oriented toward the cavities of the tunnels. Compounds Sm(2)Mn(Te(5)O(13))Cl(2) and Dy(2)Cu(Te(5)O(13))Br(2) are isostructural. The lanthanide(III) ions are eight-coordinated by eight oxygens, and the divalent transition metal ion is octahedrally coordinated by six oxygens. Two types of polymeric tellurium(IV) oxide anions are formed: Te(3)O(8)(4)(-) and Te(4)O(10)(4)(-). The interconnection of the lanthanide(III) and divalent transition metal ions by the above two types of polymeric tellurium(IV) oxide anions leads to a 3D network with long, narrow-shaped tunnels along the b-axis. The halide anions remain isolated and are located at the above tunnels. Nd(4)Cu(TeO(3))(5)Cl(3) features a different structure. All five of the Nd(III) ions are eight-coordinated (NdO(8) for Nd(1), Nd(2), Nd(4), and Nd(5) and NdO(7)Cl for Nd(3)), and the copper(I) ion is tetrahedrally coordinated by four chloride anions. The interconnection of Nd(III) ions by bridging tellurite anions resulted in a 3D network with large tunnels along the b-axis. The CuCl(4) tetrahedra are interconnected into a 1D two-unit repeating (zweier) chain via corner-sharing. These 1D copper(I) chloride chains are inserted into the tunnels of the neodymium(III) tellurite via Nd-Cl-Cu bridges. Luminescent studies show that ErCuTe(2)O(6)Cl and Nd(4)Cu(TeO(3))(5)Cl(3) exhibit strong luminescence in the near-IR region. Magnetic measurements indicate the antiferromagnetic interactions between magnetic centers in these compounds.     

Mechanistic implications of proton transfer coupled to electron transfer.

The kinetics of electron transfer for the reactions cis-[Ru(IV)(bpy)2(py)(O)]2+ + H+ + [Os(II)(bpy)3]2+ <==> cis-[Ru(III)(bpy)2(py)(OH)]2+ + [Os(III)(bpy)3]3+ and cis-[Ru(III)(bpy)2(py)(OH)]2+ + H+ + [Os(II)(bpy)3]2+ <==> cis-[Ru(II)(bpy)2(py)(H2O)]2+ + [Os(III)(bpy)3]3+ have been studied in both directions by varying the pH from 1 to 8. The kinetics are complex but can be fit to a double "square scheme" involving stepwise electron and proton transfer by including the disproportionation equilibrium, 2cis-[Ru(III)(bpy)2(py)(OH)]2+ <==> (3 x 10(3) M(-1) x s(-1) forward, 2.1 x 10(5) M(-1) x s(-1) reverse) cis-[Ru(IV)(bpy)2(py)(O)]2+ + cis-[Ru(II)(bpy)2(py)(H2O)]2+. Electron transfer is outer-sphere and uncoupled from proton transfer. The kinetic study has revealed (1) pH-dependent reactions where the pH dependence arises from the distribution between acid and base forms and not from variations in the driving force; (2) competing pathways involving initial electron transfer or initial proton transfer whose relative importance depends on pH; (3) a significant inhibition to outer-sphere electron transfer for the Ru(IV)=O2+/Ru(III)-OH2+ couple because of the large difference in pK(a) values between Ru(IV)=OH3+ (pK(a) < 0) and Ru(III)-OH2+ (pK(a) > 14); and (4) regions where proton loss from cis-[Ru(II)(bpy)2(py)(H2O)]2+ or cis-[Ru(III)(bpy)2(py)(OH)]2+ is rate limiting. The difference in pK(a) values favors more complex pathways such as proton-coupled electron transfer.     

The inhibitory effect of bis[2-[(E)-2-octenoylamino]ethyl] disulfide on the cyclooxygenase pathway

Bis[2-[(E)-2-octenoylamino]ethyl] disulfide (compd. I-3) inhibited collagen- and arachidonic acid-induced rat platelet aggregation, although not adenosine 5'-diphosphate (ADP)-induced rat platelet aggregation. Based on these results, we then investigated the inhibitory effect of compd. I-3 on thromboxane B2 formation from arachidonic acid in rat platelets, and prostaglandin I2 formation in rat aortae. Compound I-3 inhibited both thromboxane B2 and prostaglandin I2 formation, suggesting that it has an inhibitory effect on cyclooxygenase. The inhibitory effect of compd. I-3 was confirmed in experiments using a crude preparation of sheep seminal vesicle microsomal prostaglandin synthetase. These findings suggested that compd. I-3 has an inhibitory effect on cyclooxygenase activity, like nonsteroidal anti-inflammatory drugs.     

Two-electron oxidation of deoxyguanosine by a Ru(III) complex without involving oxygen molecules through disproportionation

Among the many mechanisms for the oxidation of guanine derivatives (G) assisted by transition metals, Ru(III) and Pt(IV) metal ions share basically the same principle. Both Ru(III)- and Pt(IV)-bound G have highly positively polarized C8-H's that are susceptible to deprotonation by OH(-), and both undergo two-electron redox reactions. The main difference is that, unlike Pt(IV), Ru(III) is thought to require O(2) to undergo such a reaction. In this study, however, we report that [Ru(III)(NH(3))(5)(dGuo)] (dGuo = deoxyguanosine) yields cyclic-5'-O-C8-dGuo (a two-electron G oxidized product, cyclic-dGuo) without O(2). In the presence of O(2), 8-oxo-dGuo and cyclic-dGuo were observed. Both [Ru(II)(NH(3))(5)(dGuo)] and cyclic-dGuo were produced from [Ru(III)(NH(3))(5)(dGuo)] accelerated by [OH(-)]. We propose that [Ru(III)(NH(3))(5)(dGuo)] disproportionates to [Ru(II)(NH(3))(5)(dGuo)] and [Ru(IV)(NH(3))(4)(NH(2)(-))(dGuo)], followed by a 5'-OH attack on C8 in [Ru(IV)(NH(3))(4)(NH(2)(-))(dGuo)] to initiate an intramolecular two-electron transfer from dGuo to Ru(IV), generating cyclic-dGuo and Ru(II) without involving O(2).     

Anthranilic acid-based inhibitors of phosphodiesterase: design, synthesis, and bioactive evaluation

Our previous studies identified two 2-benzoylaminobenzoate derivatives 1, which potently inhibited superoxide (O(2)˙(-)) generation induced by formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) in human neutrophils. In an attempt to improve their activities, a series of anthranilic acid derivatives were synthesized and their anti-inflammatory effects and underlying mechanisms were investigated in human neutrophils. Of these, compounds 17, 18, 46, 49, and 50 showed the most potent inhibitory effect on FMLP-induced release of O(2)˙(-) in human neutrophils with IC(50) values of 0.20, 0.16, 0.15, 0.06, and 0.29 μM, respectively. SAR analysis showed that the activities of most compounds were dependent on the ester chain length in the A ring. Conversely, a change in the linker between the A and B ring from amide to sulfonamide or N-methyl amide, as well as exchanges in the benzene rings (A or B rings) by isosteric replacements were unfavorable. Further studies indicated that inhibition of O(2)˙(-) production in human neutrophils by these anthranilic acids was associated with an elevation in cellular cAMP levels through the selective inhibition of phosphodiesterase 4. Compound 49 could be approved as a lead for the development of new drugs in the treatment of neutrophilic inflammatory diseases.     

Coordination and Redox Chemistry of Substituted-Polypyridyl Complexes of Ruthenium

The complexes [Ru(tpy)(acac)(Cl)], [Ru(tpy)(acac)(H(2)O)](PF(6)) (tpy = 2,2',2"-terpyridine, acacH = 2,4 pentanedione) [Ru(tpy)(C(2)O(4))(H(2)O)] (C(2)O(4)(2)(-) = oxalato dianion), [Ru(tpy)(dppene)(Cl)](PF(6)) (dppene = cis-1,2-bis(diphenylphosphino)ethylene), [Ru(tpy)(dppene)(H(2)O)](PF(6))(2), [Ru(tpy)(C(2)O(4))(py)], [Ru(tpy)(acac)(py)](ClO(4)), [Ru(tpy)(acac)(NO(2))], [Ru(tpy)(acac)(NO)](PF(6))(2), and [Ru(tpy)(PSCS)Cl] (PSCS = 1-pyrrolidinedithiocarbamate anion) have been prepared and characterized by cyclic voltammetry and UV-visible and FTIR spectroscopy. [Ru(tpy)(acac)(NO(2))](+) is stable with respect to oxidation of coordinated NO(2)(-) on the cyclic voltammetric time scale. The nitrosyl [Ru(tpy)(acac)(NO)](2+) falls on an earlier correlation between nu(NO) (1914 cm(-)(1) in KBr) and E(1/2) for the first nitrosyl-based reduction 0.02 V vs SSCE. Oxalate ligand is lost from [Ru(II)(tpy)(C(2)O(4))(H(2)O)] to give [Ru(tpy)(H(2)O)(3)](2+). The Ru(III/II) and Ru(IV/III) couples of the aqua complexes are pH dependent. At pH 7.0, E(1/2) values are 0.43 V vs NHE for [Ru(III)(tpy)(acac)(OH)](+)/[Ru(II)(tpy)(acac)(H(2)O)](+), 0.80 V for [Ru(IV)(tpy)(acac)(O)](+)/[Ru(III)(tpy)(acac)(OH)](+), 0.16 V for [Ru(III)(tpy)(C(2)O(4))(OH)]/[Ru(II)(tpy)(C(2)O(4))(H(2)O)], and 0.45 V for [Ru(IV)(tpy)(C(2)O(4))(O)]/[Ru(III)(tpy)(C(2)O(4))(OH)]. Plots of E(1/2) vs pH define regions of stability for the various oxidation states and the pK(a) values of aqua and hydroxo forms. These measurements reveal that C(2)O(4)(2)(-) and acac(-) are electron donating to Ru(III) relative to bpy. Comparisons with redox potentials for 21 related polypyridyl couples reveal the influence of ligand changes on the potentials of the Ru(IV/III) and Ru(III/II) couples and the difference between them, DeltaE(1/2). The majority of the effect appears in the Ru(III/II) couple. ()A linear correlation exists between DeltaE(1/2) and the sum of a set of ligand parameters defined by Lever et al., SigmaE(i)(L(i)), for the series of complexes, but there is a dramatic change in slope at DeltaE(1/2) approximately -0.11 V and SigmaE(i)(L(i)) = 1.06 V. Extrapolation of the plot of DeltaE(1/2) vs SigmaE(i)(L(i)) suggests that there may be ligand environments in which Ru(III) is unstable with respect to disproportionation into Ru(IV) and Ru(II). This would make the two-electron Ru(IV)O/Ru(II)OH(2) couple more strongly oxidizing than the one-electron Ru(IV)O/Ru(III)OH couple.     

Parallel approach for solution-phase synthesis of 2-quinoxalinol analogues and their inhibition of LPS-induced TNF-alpha release on mouse macrophages in vitro

A parallel solution-phase synthesis of 2-quinoxalinol analogues is described. The key step-simultaneous reductions of m-Ar(NO(2))(2) to m-Ar(NH(2))(2) was investigated extensively. We obtained preliminary pharmacological activity of those analogues for the inhibition of LPS-induced TNF-alpha release on mouse macrophage in vitro. Two compounds revealed inhibitory activity, with IC(50) values of 0.40 microM (7-amino-6-[(3-methoxypropyl)amino]-3-methyl-2-quinoxalinol) and 2.2 microM (7-amino-6-[(3-butoxypropyl)amino]-3-methyl-2-quinoxalinol), respectively.     

Effects of 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide on various ulcer models in rats.

The effects of 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide (compd. III-1a) on various experimental ulcers were investigated. The oral administration of compd. III-1a at doses ranging from 30 to 300 mg/kg inhibited the acute gastric ulcerations induced by ethanol, HCl.aspirin and indomethacin in rats. Compound III-1a significantly inhibited the water immersion stress-induced gastric ulcer at doses of 3 mg/kg, p.o. The anti-ulcer activity of plaunotol as a reference drug was equivalent on an ethanol-induced ulcer to that of compd. III-1a, but weaker on HCl.aspirin, indomethacin and stress-induced ulcers than that of compd. III-1a. On indomethacin-produced gastric antral ulcer, compd. III-1a showed the same significant inhibitory activity as spizofurone did at a dose of 100 mg/kg, p.o. Compound III-1a also inhibited hemorrhagic shock-, diethyldithiocarbamic acid (DDC)-and platelet activating factor (PAF)-induced ulcers dose-dependently. Plaunotol only showed significant inhibitory activity on PAF-induced ulcer in these three ucler models. The consecutive administration of compd. III-1a (100 mg/kg, p.o.) twice a day significantly accelerated the healing of an acetic acid-induced ulcer and that of plaunotol (200 mg/kg, p.o.) showed the same activity. Moreover, orally administered compd. III-1a at a dose of 100 mg/kg decreased the gastric acid secretion in pylorus-ligated rats. The results in the present study suggest that compd. III-1a has the dual action on ulcer formation.     

First example of mu(3)-sulfido bridged mixed-valent triruthenium complex triangle Ru(III)(2)Ru(II)(O,O-acetylacetonate)(3)(mu-O,O,gamma-C-acetylacetonate)(3)(mu(3)-S) (1) incorporating simultaneous O,O- and gamma-C-bonded bridging acetylacetonate units. Synthesis,crystal structure,and spectral and redox properties

The reaction of mononuclear ruthenium precursor [Ru(II)(acac)(2)(CH(3)CN)(2)] (acac = acetylacetonate) with the thiouracil ligand (2-thiouracil, H(2)L(1) or 6-methyl -2-thiouracil, H(2)L(2)) in the presence of NEt(3) as base in ethanol solvent afforded a trinuclear triangular complex Ru(3)(O,O-acetylacetonate)(3)(mu-O,O,gamma-C-acetylacetonate)(3)(mu(3)-sulfido) (1). In 1, each ruthenium center is linked to one usual O,O-bonded terminal acetylacetonate molecule whereas the other three acetylacetonate units act as bridging functions: each bridges two adjacent ruthenium ions through the terminal O,O-donor centers at one end and via the gamma-carbon center at the other end. Moreover, there is a mu(3)-sulfido bridging in the center of the complex unit, which essentially resulted via the selective cleavage of the carbon-sulfur bond of the thiouracil ligand. In diamagnetic complex 1, the ruthenium ions are in mixed valent Ru(III)Ru(III)Ru(II) state, where the paramagnetic ruthenium(III) ions are antiferromagnetically coupled. The single crystal X-ray structure of 1 showed two crystallographically independent C(3)-symmetric molecules, Ru(3)(O,O-acetylacetonate)(3)(mu-O,O,gamma-C-acetylacetonate)(3)(mu(3)-S) (1), in the asymmetric unit. Bond distances of both crystallographically independent molecules are almost identical, but there are some significant differences in bond angles (up to 6 degrees ) and interplanar angles (up to 8 degrees ). Each ruthenium atom exhibits a distorted octahedral environment formed by four oxygen atoms, two from each of the terminal and bridging acetylacetonate units, one gamma-carbon of an adjacent acetylacetonate ligand, and the sulfur atom in the center of the complex. In agreement with the expected 3-fold symmetry of the complex molecule, the (1)H and (13)C NMR spectra of 1 in CDCl(3) displayed signals corresponding to two types of ligand units. In dichloromethane solvent, 1 exhibited three metal center based successive quasireversible redox processes, Ru(III)Ru(III)Ru(III)-Ru(III)Ru(III)Ru(II) (couple I, 0.43 V vs SCE); Ru(III)Ru(III)Ru(IV)-Ru(III)Ru(III)Ru(III) (couple II, 1.12 V); and Ru(III)Ru(III)Ru(II)-Ru(III)Ru(II)Ru(II) (couple III, -1.21 V). However, in acetonitrile solvent, in addition to the three described couples [(couple I), 0.34 V; (couple II), 1.0 V; (couple III), -1.0], one irreversible oxidative response (Ru(III)Ru(III)Ru(IV) --> Ru(III)Ru(IV)Ru(IV) or oxidation of the coordinated sulfide center) appeared at E(pa), 1.50 V. The large differences in potentials between the successive couples are indicative of strong coupling between the ruthenium ions in the mixed-valent states. Compound 1 exhibited a moderately strong charge-transfer (CT) transition at 654 nm and multiple ligand based intense transitions in the UV region. In the Ru(III)Ru(III)Ru(III) (1(+)) state, the CT band was slightly blue shifted to 644 nm; however, the CT band was further blue shifted to 520 nm on two-electron oxidation to the Ru(III)Ru(III)Ru(IV) (1(2+)) state with a reduction in intensity.     

Hybrid open-framework iron phosphate--oxalates demonstrating a dual role of the oxalate unit

New inorganic-organic hybrid open-framework materials of the phosphate-oxalate family, [Fe2(H2O)2-(HPO4)2(C2O4)].H2O (I), [Fe2(H2O)2-(HPO4)2(C2O4)].2H2O (II), [C3N2H12]-[Fe2(HPO4)2(C2O4)1.5]2 (III), and [C3N2OH12][Fe2(HPO4)2(C2O4)1.5]2 (IV) have been synthesized hydrothermally in the presence of structure-directing amines. The amine molecules are incorporated in III and IV, whereas I and II are devoid of them. The oxalate units act as a bridge between the layers in all the compounds. The layers in I and II are entirely inorganic, being formed by FeO6 and PO4 units, whereas in III and IV oxalate units constitute the inorganic layers and act as the bridge between these layers. Such a dual role of the oxalate unit is unique and noteworthy. The formation of two types of inorganic layers in I and II consisting of four-, six-, and eight-membered rings, indicates the interconversions between the various rings in the phosphate--oxalates to be facile. All the phosphate--oxalates show antiferromagnetic ordering at low temperatures.     

Non-oxo 5-coordinate and 6-coordinate vanadium(IV) complexes with their precursor [LV(III)(CH3OH)](0), where L = a trianionic aminetris(phenolate)-[N,O,O,O] donor ligand: a magnetostructural and EPR study

Ligating properties of a tripodal, potentially tetradentate aminetris(phenol) ligand, tris(2-hydroxy-3,5-di-tert-butylbenzyl)amine, H(3)L, containing [N,O,O,O] donor atoms toward the vanadium ions in +III and IV oxidation states have been studied. The structures of complexes 1 [LV(III)(CH(3)OH)](0), 2 [LV(IV)(OCH(3))](0) and 3 [LV(IV)(acac)](0) were determined by X-ray diffraction methods as having five-coordinate V(III), 1, five-coordinate non-oxo-vanadium(IV), 2, and six-coordinate non-oxo-vanadium(iv) 3, respectively. Compounds 1-3 were also studied with electrochemical methods, variable-temperature (2-295 K) magnetic susceptibility measurements and X-band electron paramagnetic resonance (EPR) spectroscopy. The electrochemical results of 2 and 3 suggest metal-centered oxidation, i.e. the generation of a V(V)-phenolate species. EPR investigations indicate a (d(xy))(1) ground state showing a considerable increase in the in-plane π-bonding, as is expected for a phenolate ligand.     

Luminol-K2S2O8体系中金属离子化学发光行为的研究

报导了在自行设计的流动注射式化学发光分析仪上,对Luminal-K2S2O8体系中32种金属离子的化学发光行为的系统研究.确定了对金属离子的最优测定条件以及大多数金属离子的检出极限和线性范围.